The design of the environmentally friendly approach to the synthesis of biologically important compounds without compromising the yield has been the focus of many chemists in recent years. The development of the one-pot synthesis of heterocycles in the presence of Ionic Liquids (ILs), used as both environmental media and catalysts, is efficient and environmentally sustainable. This review highlights the one-pot synthesis of imidazoles in acidic ILs in the past decade. Some reviews have been conducted on imidazoles, such as their pharmacological importance. Hence, we decided to focus on their synthesis in acidic ionic liquids, which the authors are not aware of any published literature.
The choice of design and synthesis of new dipeptide derivatives is due to their broad pharmacological activities against various diseases. In present study, eight novel dipeptides incorporating sulphonamide functionality (8a-h) were synthesised via the reaction of benzenesulphonyl chloride and L-proline to afford benzenesulphonamides. The condensation reaction of benzenesulphonamides and carboxamide derivatives, using peptide coupling reagents afforded the dipeptide compounds (8a-h). The structural validation of the compounds was done using IR, 1H NMR, 13C NMR and MS spectrometry. Molecular docking studies revealed favourable interactions between the compounds and key amino acid residues in the active site of the protein targets. The drug-likeness study showed that the compounds comply with Lipinski’s rule of five, indicating strong potential as orally bioavailable candidates. Compound 8a exhibited superior antidiabetic activity compared to the standard clinical drug, acarbose. Antioxidant screening demonstrated that compound 8g, with an IC50 value of 0.214 µg/mL, exhibited comparable activity to ascorbic acid (IC50: 0.213 µg/mL). In the carrageenan-induced rat paw edema bioassay, at 0.5 h, compounds 8a-h showed strong anti-inflammatory inhibition with percentage inhibition in the range of 97.67-86.64 %, compared to the reference drug, indomethacin (75.55 %). Some of the dipeptide derivatives are identified as promising therapeutic agents for further studies.